evaluate the pharmaceuticals company byetta on amgen and glp-1 Advanced Intra-Oral Spray, by Results RNA, 4 oz This gentle Glucagon-Like Peptide 1 (GLP-1) Agonists
Description
In May 2025, Bank of America set a $70 price target, crowing about the Novo Nordisk deal as a growth rocket for Hims weight loss segment
GLP-1 agonists are medications designed to replicate the effects of a natural hormone in the body called glucagon-like peptide-1
Villumsen M et al
The peptides obtained from this method contain about 70% crude protein, 1.3% crude fat, and 17% carbohydrates, which contribute to their effective properties
All of the dynamics around GLP-1s, compounding shortage workarounds, and potential for DTC telehealth fallout I described last August seem to be playing out in 2025
Stability Testing of new Drug Substances and Products [Internet]
